Bill Berkrot

(Reuters) - Celgene Corp said its Abraxane drug helped patients with advanced pancreatic cancer live an average of two months longer than chemotherapy and significantly increased the percentage of those...

NEW YORK (Reuters) - Teva Pharmaceutical Industries' new Chief Executive Jeremy Levin promised on Tuesday to reshape the company into "the most indispensable medicines company in the world" and to...

NEW YORK (Reuters) - Teva Pharmaceutical Industries' new Chief Executive Jeremy Levin promised on Tuesday to reshape the company into "the most indispensable medicines company in the world" and to...

(Reuters) - A new blood clot preventer from Pfizer Inc and Bristol-Myers Squibb Co reduced the risk of recurrence of clots in veins and lungs and death by 80 percent...

(Reuters) - A new blood clot preventer from Pfizer Inc and Bristol-Myers Squibb Co reduced the risk of recurrence of clots in veins and lungs and death by 80 percent...

(Reuters) - U.S. price increases on popular branded drugs in the past year have been more than six times the overall rate of inflation for consumer goods, while spending on...

(Reuters) - European health regulators on Tuesday approved an eagerly anticipated blood thinner developed by Bristol-Myers Squibb Co and Pfizer Inc for preventing strokes and blood clots in patients with...

(Reuters) - European health regulators on Tuesday approved an eagerly anticipated blood thinner developed by Bristol-Myers Squibb Co and Pfizer Inc for preventing strokes and blood clots in patients with...

WASHINGTON/NEW YORK (Reuters) - U.S. Republican lawmakers accused federal health regulators on Wednesday of failing to prevent a deadly fungal meningitis outbreak by not acting much earlier to shut down...

WASHINGTON/NEW YORK (Reuters) - U.S. Republican lawmakers accused federal health regulators on Wednesday of failing to prevent a deadly fungal meningitis outbreak by not acting much earlier to shut down...